Researchers locate protein that could 'turn off' deadly disease carrier

January 12, 2012

Researchers from Boston College have discovered a protein that plays a pivotal role in the progression of the deadly diseases toxoplasmosis and malaria and shown that its function could be genetically blocked in order to halt the progress of the parasite-borne illnesses, the team reports in the current edition of the journal Science.

The protein, identified as DOC2.1, plays a similar role in the secretion of microneme organelles that are crucial to the mobility of the parasitic protozoa Toxoplasma gondii, which causes , and , which causes malaria, report Marc-Jan Gubbels and Gabor Marth, both professors of biology at Boston College.

The researchers say the discovery could lead to the development of drugs that target the protein in order to block the mechanism that advances the two diseases.

"The mechanism of microneme secretion, which is required for host cell invasion, is a valid ," said Gubbels. "Since neither microneme secretion nor invasion itself are currently targeted by any anti-malaria drugs, a potentially new class of anti-malaria reagents can be developed. The high incidence of against malaria is a big problem, so are urgently needed."

Gubbels said researchers in his lab obtained a temperature-sensitive mutant of Toxoplasma gondii, which displayed a mobility defect preventing it from host cell invasion. Marth, a computational biologist, sequenced the parasite's genome and identified 33 possible sites in the genome responsible for the defect. Lab work isolated a single mutation in the DOC2.1 gene that was associated with a microneme secretion defect responsible for the mobility defect.

Co-author Manoj T. Duraisingh, of the Harvard School of Public Health, generated a Plasmodium mutant wherein DOC2.1 expression could be shut off and demonstrated the protein was also crucial to microneme secretion in the parasite that causes malaria.

Gubbels said the findings reinforce the dramatic advances made possible by complete genome sequencing and computational biology, which are Marth's areas of expertise. These approaches bypass the need for the difficult and time-consuming task of mapping causative mutations by genetic crosses as used in model organisms.

"The re-sequencing method will permit the study of eukaryotic pathogens by forward genetics, which has shown its power in studies of model organisms, such as yeast and fruit flies," said Gubbels. "To date, many of these pathogens have limited experimental and genetic accessibility, but this roadblock can now be lifted."

Added Marth, "We are now working with a number of research teams to gain insight into other critical pathogenic pathways, and already see promising initial results."

Researchers from Children's Hospital Boston and University of Oxford (U.K.) also contributed to the research.

Explore further: A new target to inhibit malaria and toxoplasmosis infection

Related Stories

A new target to inhibit malaria and toxoplasmosis infection

July 25, 2011

Maryse Lebrun, Research Director at Inserm, and her fellow researchers at the Laboratoire Dynamique des interactions membranaires normales et pathologiques (CNRS, France), have characterised a protein complex that allows ...

Recommended for you

Artificial beta cells

December 8, 2016

Researchers led by ETH Professor Martin Fussenegger at the Department of Biosystems Science and Engineering (D-BSSE) in Basel have produced artificial beta cells using a straightforward engineering approach.

Key regulator of bone development identified

December 8, 2016

Loss of a key protein leads to defects in skeletal development including reduced bone density and a shortening of the fingers and toes—a condition known as brachydactyly. The discovery was made by researchers at Penn State ...

Researchers question lifelong immunity to toxoplasmosis

December 8, 2016

Medical students are taught that once infected with Toxoplasma gondii—the "cat parasite"—then you're protected from reinfection for the rest of your life. This dogma should be questioned, argue researchers in an Opinion ...

TET proteins drive early neurogenesis

December 7, 2016

The fate of stem cells is determined by series of choices that sequentially narrow their available options until stem cells' offspring have found their station and purpose in the body. Their decisions are guided in part by ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.